Skip to content
HOME
THE FIRM
TEAM
PORTFOLIO
INVESTORS
CONNECT
HOME
THE FIRM
TEAM
PORTFOLIO
INVESTORS
CONNECT
Home
The firm
Team
Portfolio
Investors
Connect
Loading stock data...
Archives:
SEC Filing
Bio-Convert Corporate Presentation (8-K), April 1, 2025
Orocidin Corporate Presentation (8-K), March 6, 2025
Corporate Presentation (8-K), January 2, 2025
Quarterly Report, June 30, 2024
Annual Report, March 31, 2024
Quarterly Report, December 31, 2023
Quarterly Report, September 30, 2023
Quarterly Report, June 30, 2023
Annual Report, July 20, 2023
8-K, June 20, 2023
Next
→
HOME
THE FIRM
TEAM
PORTFOLIO
INVESTORS
CONNECT
HOME
THE FIRM
TEAM
PORTFOLIO
INVESTORS
CONNECT
Home
The firm
Team
Portfolio
Investors
Connect